Compare Humana Inc (HUM) vs iShares Gold Trust (IAU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs iShares Gold Trust — how do they compare? Humana Inc trades at $437.84 (market cap $47.61B), while iShares Gold Trust trades at $78.82 (market cap $61.03B). The key difference: iShares Gold Trust is the larger of the two by market cap, and Humana Inc pays a 0.89% dividend while iShares Gold Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and iShares Gold Trust for 49 Days on average.
| HUM | IAU | |
|---|---|---|
Market Cap | $47.61B | $61.03B |
Volume | 1,827,332 | 3,374,602 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $409.85 | $101.57 |
52-Week Low | $163.67 | $74.21 |
Typical Hold Time | 53 Days | 49 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
IAU shares declined 1.67% to $77.06 amid bearish technical signals, with moving averages and oscillators indicating selling pressure. The stock faces headwinds from rising Treasury yields and Federal Reserve rate uncertainty, though some analysts see potential for recovery if inflation data continues to soften. Recent news highlights gold's sensitivity to economic indicators and monetary policy expectations.
The outlook remains cautious with technical indicators favoring bearish momentum, but potential exists for rebound if rate-hike expectations diminish. Key risks include persistent high yields and dollar strength, while opportunities may emerge from safe-haven demand during market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About iShares Gold Trust
IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.
Read more on IAU →
